EDITORIAL
Accepted on 15 Jan 2026
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Nanomaterials Mediated Immunomodulation in Cancer: Current Perspective from Bench to Clinic
Nanomaterials Mediated Immunomodulation in Cancer: Current Perspective from Bench to Clinic
3,769
Total downloads
24k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 14 Nov 2025
Phytochemical and nanoparticle-based therapeutic potential of Sphaeranthus indicus against hepatocellular carcinoma via cryptomeridiol targeting
doi 10.3389/fonc.2025.1691905
- 921 views
ORIGINAL RESEARCH
Published on 22 Oct 2025
Immunodiagnostic profiling of SPON2 and MSMB as biomarkers in prostate cancer for nanomaterial- based detection strategies
doi 10.3389/fimmu.2025.1677562
- 1,365 views
ORIGINAL RESEARCH
Published on 14 Oct 2025
Nanomaterial-assisted immunodiagnostic profiling and therapeutic targeting of hepatocellular carcinoma: from molecular biomarkers to clinical applications
doi 10.3389/fimmu.2025.1668630
- 1,465 views
- 1 citation
ORIGINAL RESEARCH
Published on 25 Aug 2025
Integrative profiling of lung cancer biomarkers EGFR, ALK, KRAS, and PD-1 with emphasis on nanomaterials-assisted immunomodulation and targeted therapy
doi 10.3389/fimmu.2025.1649445
- 2,607 views
REVIEW
Published on 14 Aug 2025
Nano-enabled strategies for targeted immunotherapy in gastrointestinal cancers
doi 10.3389/fimmu.2025.1653829
- 2,047 views
- 1 citation
REVIEW
Published on 12 Aug 2025
Smart CAR-T Nanosymbionts: archetypes and proto-models
doi 10.3389/fimmu.2025.1635159
- 5,883 views
- 4 citations
MINI REVIEW
Published on 25 Jun 2025
Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade
doi 10.3389/fimmu.2025.1611299
- 2,176 views
- 6 citations
ORIGINAL RESEARCH
Published on 02 May 2025
Immunomodulatory effects of intratumoral cowpea mosaic virus and calreticulin nanoparticles in canine tumors: early results
doi 10.3389/fimmu.2025.1566394
- 3,434 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore